Market cap: $3,231,050
Exchange: ASE
Sector: Health Technology
NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing products for the eye care market. Its products include Avenova, NeutroPhase, and CelleRx. The company was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA.
Company Name
Novabay Pharmaceuticals Inc
Average Volume (10 days)
1,823,326
Average Volume (30 days)
2,865,936
Moving Average (50 days)
$0.1286
Moving Average (200 days)
$0.2384
Ex-Divided Date
n/a
Dividend Yield
0
P/E Ratio
0
Market Cap
3,231,050
Shares Outstanding
36,060,825
52-Week High Split Adjust Only
1.95
52-Week Low Split Adjust Only
0.082
Employee Count
56
Beta
0.1605
Next Earnings Date
2024-05-09
TTM Dividend Rate Per Share
0
Past 5 days
-0.14%
Past 30 days
-0.36%
Past 3 months
-0.46%
Past 6 months
-0.76%
Past year
-0.94%
Past 2 years
-0.99%
Past 5 years
-1%
Max % Change
-1%
| Name | Ticker | Price/Sales (ttm) | Price/Book (ttm) | Forward P/E | PEG Ratio | EV/Revenue |
|---|---|---|---|---|---|---|
| NovaBay Pharmaceuticals Inc. | NBY | n/a | n/a | n/a | n/a | n/a |
| Peer Avg | N/A | 2.38 | 2.79 | 2.4 | 2.38 | 2.20 |
| Johnson & Johnson | JNJ | 5.29 | 6.77 | n/a | 5.29 | 5.40 |
| SIGA Technologies Inc | SIGA | 4.22 | 4.37 | 9.4 | 4.22 | 3.38 |
| NanoViricides Inc. | NNVC | n/a | n/a | n/a | n/a | n/a |
| Oragenics Inc. | OGEN | n/a | n/a | n/a | n/a | n/a |